Download PDF
Eur J Pediatr Surg 2013; 23(04): 325-326
DOI: 10.1055/s-0032-1323160
Case Gallery
Georg Thieme Verlag KG Stuttgart · New York

Secondary Anastomosis after Preoperative Botulinum Type A Toxin Injection in a Case with Long Gap Oesophageal Atresia

Mark Ellebæk
1   Department of Surgery, Odense University Hospital, Odense, Denmark
,
Niels Qvist
1   Department of Surgery, Odense University Hospital, Odense, Denmark
,
Lars Rasmussen
1   Department of Surgery, Odense University Hospital, Odense, Denmark
› Author Affiliations
Further Information

Publication History

28 February 2012

04 June 2012

Publication Date:
17 August 2012 (online)

    Permissions and Reprints

Introduction

The treatment of long gap oesophageal atresia is challenging. Primary gastric pull-up or secondary anastomosis, after awaiting the spontaneous growth of the upper and lower pouch or elongation techniques, are the most common methods.[1] [2] The gastric pull-up and colonic interposition may result in long-term functional problems and delayed primary anastomosis may be difficult or impossible due to insufficient elongation. We present a case where intramural botulinum type A toxin injection in the proximal and distal pouch resulted in an additional elongation making secondary anastomosis possible.

 

  • References

  • 1 Bagolan P, Iacobelli Bd B, De Angelis P , et al. Long gap esophageal atresia and esophageal replacement: moving toward a separation?. J Pediatr Surg 2004; 39 (7) 1084-1090
    CrossrefPubMedGoogle Scholar
  • 2 Foker JE, Kendall TC, Catton K, Khan KM. A flexible approach to achieve a true primary repair for all infants with esophageal atresia. Semin Pediatr Surg 2005; 14 (1) 8-15
    CrossrefPubMedGoogle Scholar
  • 3 Vogt EC. Congenital esophageal atresia. Am J Roentgenol 1929; 22: 463-465
    PubMedGoogle Scholar
  • 4 Gross RE. The surgery of infancy and childhood. Philadelphia: WB Saunders; 1953
    Google Scholar
  • 5 Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994; 121 (8) 590-591
    CrossrefPubMedGoogle Scholar
  • 6 Gui D, Rossi S, Runfola M, Magalini SC. Review article: botulinum toxin in the therapy of gastrointestinal motility disorders. Aliment Pharmacol Ther 2003; 18 (1) 1-16
    PubMedGoogle Scholar
  • 7 Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr 2005; 63 (1) 180-185
    CrossrefPubMedGoogle Scholar
  • 8 Chumpitazi BP, Fishman SJ, Nurko S. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter. Am J Gastroenterol 2009; 104 (4) 976-983
    CrossrefPubMedGoogle Scholar
  • 9 Steinwegs I, Mach-Detiefsen B, Boemers T. Botox injection for primary oesophageal anastomosis in two preterm's with oesophageal atresia type IIIA and type II. Presented at the 12th European Congress of Paediatric Surgery, Barcelona, 15–18 June 2011.
    PubMedGoogle Scholar
  • 10 Friedenberg F, Gollamudi S, Parkman HP. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004; 49 (2) 165-175
    CrossrefPubMedGoogle Scholar
  • 11 James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol 2003; 285 (2) G291-G297
    PubMedGoogle Scholar